Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material.
Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992.
For patients, we provide the latest patient information leaflets and training materials as well as the technical information for Berlin-Chemie products available in Germany via our Medical Hub.
Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.
Discover More about Global Responsibility
From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet
Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice.
Discover More about Global Partnering
Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.
Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.
Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.
Menarini Blog
Follow Us
We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.
Our Job Portal
Find out about our current vacancies at Berlin-Chemie directly on our career portal.
2011 - 09 - 15
An important innovation for people with diabetes, thanks to Menarini research
|
|
|
PRESS RELEASE
Florence, 15th September, 2011
At the 47th European EASD congress (European Association for Studies on Diabetes), held this month in Lisbon, A. Menarini Diagnostics presented their latest instrument, the GlucoMen LX Plus, a glucometer which allows diabetic patients to check not only their glucose but also their ketone levels, from one tiny blood sample.
Ketones in the blood are indicative of an impaired glucose metabolism, linked to changes in the concentration or ineffectiveness of insulin in the body. This may occur in a number of circumstances and may be caused by other unrelated illnesses or by pharmacological treatments which, in a range of different ways, may trigger off significant and repeated fluctuations in the amount of insulin released into the patient’s bloodstream.
When this happens, the organism starts to produce ketones which, if they exceed a certain level and go untreated, may give rise to DKA or Diabetic Ketoacidosis, a condition which, in extreme cases can lead to diabetic coma.
GlucoMen LX Plus is the very first system which allows patients to test their ketone levels in a safe and discreet way, using the same instrument they would use to test their blood glucose, without the need to calibrate or engage in complicated or risky handling.
Crescenzio Izzo, General Manager of A. Menarini Diagnostics, at the moment of the European launch of the GlucoMen LX Plus, commented: "We are proud to be able to offer, once again, an important and exclusive contribution towards improving the quality of life of diabetic patients, helping not only those who suffer from this chronic condition but also all those healthcare professionals who assiduously seek to reduce the social impact of the disease. In times as difficult and complex as these, when we are all called upon to curb public expenditure in the healthcare sector, A. Menarini Diagnostics has both strenthened and confirmed its commitment to carrying out research with the aim of reducing the cost of diabetes management: and the GlucoMen LX Plus is the epitome of this more than 30 year undertaking."
For further details on Glucomen LX Plus+ click here